3rd Annual Miami Lung Cancer Conference
In-Person Event
Mar 19, 2016
Miami Beach, Florida, USASpeakers
OVERVIEW
3rd Annual Miami Lung Cancer Conference is organized by Physicians Education Resource, LLC (PER) and would be held on Mar 19, 2016 at Eden Roc Miami, Miami, Florida, United States of America. The targeted audience for this medical event basically for oncologists involved in the treatment and management of patients with lung cancers. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, fellows, and other healthcare professionals.
This 1-day meeting will address immunotherapies and targeted agents both approved and in development, treatment for special populations, and a look forward from the experts. This CME conference has been approved with 6.0 AMA PRA Category 1 Credits.
Learning Objectives
At the conclusion of this symposium, you should be better prepared to:
• Discuss evidence-based recommendations regarding tumor tissue testing and its role in therapeutic selection for the patients with NSCLC
• Assess clinical decision-making necessary along multiple lines of care concerning the use of chemotherapeutic, targeted, and immunooncology strategies in the setting of NSCLC
• Discuss evolving data sets on immunooncology strategies and their use in lung cancers
• Describe the role of cytotoxic and antiangiogenic approaches in the management of advanced NSCLC
• Explain optimized strategies to target oncogenic drivers in frontline settings and beyond disease progression
• Describe advances and future directions for care in the management of squamous NSCLC, as well as treatment considerations for special populations of patients with lung cancer
• Integrate personalized approaches to manage challenging cases and real-world clinical scenarios in advanced lung cancer settings
This 1-day meeting will address immunotherapies and targeted agents both approved and in development, treatment for special populations, and a look forward from the experts. This CME conference has been approved with 6.0 AMA PRA Category 1 Credits.
Learning Objectives
At the conclusion of this symposium, you should be better prepared to:
• Discuss evidence-based recommendations regarding tumor tissue testing and its role in therapeutic selection for the patients with NSCLC
• Assess clinical decision-making necessary along multiple lines of care concerning the use of chemotherapeutic, targeted, and immunooncology strategies in the setting of NSCLC
• Discuss evolving data sets on immunooncology strategies and their use in lung cancers
• Describe the role of cytotoxic and antiangiogenic approaches in the management of advanced NSCLC
• Explain optimized strategies to target oncogenic drivers in frontline settings and beyond disease progression
• Describe advances and future directions for care in the management of squamous NSCLC, as well as treatment considerations for special populations of patients with lung cancer
• Integrate personalized approaches to manage challenging cases and real-world clinical scenarios in advanced lung cancer settings
KEY DATES
19 Mar, 2016
Event Start Date
19 Mar, 2016
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
Eden Roc Miami BeachRELATED CONFERENCES & LIVE WEBINARS
Quick Links